openPR Logo
Press release

Myelodysplastic Syndromes Market Business Growth Analysis, Trend, Outlook, Share, and Top Companies are Boston Biomedical, AbbVie Inc., Acceleron Pharma, Inc., BerGenBio ASA

06-30-2020 03:25 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Myelodysplastic Syndromes Market

Myelodysplastic Syndromes Market

Myelodysplastic Syndromes Market research report comprises of several parameters which are thoroughly studied by the experts. Market research analysis and data lend a hand to businesses for the planning of production, product launches, costing, inventory, purchasing and marketing strategies. This market study considers a market attractiveness analysis, where each segment is benchmarked based on its market size, growth rate, and general attractiveness. Market info can be explained more specifically in terms of breakdown of data by manufacturers, region, type, application, market status, market share, growth rate, future trends, market drivers, opportunities, challenges, emerging trends, risks and entry barriers, sales channels, and distributors.

Global myelodysplastic syndromes market is rising gradually with a healthy CAGR of 11.09% in the forecast period of 2019-2026. Increasing geriatric population, growing awareness about the diseases and improving healthcare expenditure are some major drivers for the market growth.

Request Sample of Global Myelodysplastic Syndromes Market 2019 @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-myelodysplastic-syndromes-market

Some of the key players from the complete study are:

Astex Pharmaceuticals,
Otsuka Holdings Co., Ltd.,
TAIHO PHARMACEUTICAL CO., LTD.,
Lupin,
Takeda Pharmaceutical Company Limited,
Onconova Therapeutics,
Helsinn Healthcare SA,
Boehringer Ingelheim International GmbH,
Johnson & Johnson Services, Inc.,
MEI Pharma Inc.,
Aprea Therapeutics,
Boston Biomedical,
AbbVie Inc.,
Acceleron Pharma, Inc.,
BerGenBio ASA,
CELGENE CORPORATION,
Eisai Co., Ltd.,
among others.

Market Definition:

Myelodysplastic syndromes are a rare group of hematological diseases that are caused by formation of abnormal blood-forming cells in the bone marrow. It occurs due to the mutation of one or more genes which controls the development of blood cells. These are also referred as bone marrow failure disorder. In myelodysplastic syndrome the bone marrow fails to produce healthy red blood cells, white blood cells and or platelets. The most common symptoms of myelodysplastic syndromes are fatigue, weakness, shortness of breath, bone pain and others. The symptoms and severity of MDS varies from person to person.

The prevalence of MSD is estimated to be approximately 22 to 45 cases per 100,000 people over the age of 70. This disease occurs slightly more in males than females. MSD can develop in any age group but it mostly affects population over the age of 60 years.

Myelodysplastic Syndromes Market Drivers

Increasing geriatric population which has a tendency of getting effected with myelodysplastic syndrome acts as a market driver

Technological advancements in the sequencing technologies also drives this market growth

Government initiatives for research and development of target specific therapies and favorable reimbursement policies will also boost this market growth in the forecast period

Growing awareness about the diseases associated with MDS is expected to drive the market growth

Myelodysplastic Syndromes Market Restraints

High cost therapies of myelodysplastic syndromes restricts the market growth

Novel treatment options due to the complexity and heterogeneity of can hamper the market growth

Order a Copy of This Research Report @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-myelodysplastic-syndromes-market

Myelodysplastic Syndromes Market Segmentation:

Myelodysplastic Syndromes Market : By Type

Myelodysplastic Syndrome with Unilineage Dysplasia
Myelodysplastic Syndrome with Multilineage Dysplasia
Myelodysplastic Syndrome with Ring Sideroblasts
Others

Myelodysplastic Syndromes Market : By Diagnosis

Complete Blood Count
Bone Marrow Aspiration and Biopsy
Others

Myelodysplastic Syndromes Market : By Treatment

Medication
Blood Transfusion
Bone Marrow Transplantation
Others

Myelodysplastic Syndromes Market : By Route of Administration

Oral
Injectable
Others

Myelodysplastic Syndromes Market : By End Users

Hospitals
Homecare
Specialty Clinics
Others

Myelodysplastic Syndromes Market : By Distribution Channels

Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Others

Myelodysplastic Syndromes Market : By Geography

North America
South America
Europe
Asia-Pacific
Middle East & Africa

Key Developments in the Myelodysplastic Syndromes Market:

In September 2019, Astex Pharmaceuticals received the Orphan Drug designation for the U. S. FDA for ASTX727, a novel oral hypomethylating agent used for treatment of patients with Myelodysplastic Syndromes (including chronic myelomonocytic leukemia). Astex Pharmaceuticals is a subsidiary of Otsuka Holdings Co., Ltd. and TAIHO PHARMACEUTICAL CO., LTD. The grant of this designation to the drug will provide a seven year market exclusivity in the United States, to the company

In November 2018, Lupin received marketing approval from the U. S. FDA for Decitabine, the generic version of dacogen for treatment of patients with myelodysplastic syndrome. This productis available in injectable dosage form and has similar efficacy to dacogen with treated and untreated, de novo and secondary MDS. This approval provides the marketing grant of Otsuka Pharmaceutical Co. Ltd.’s dacogen and increase the market size of Lupin

Myelodysplastic Syndromes Market Competitive Analysis:

Global myelodysplastic syndromes market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of myelodysplastic syndromes market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report

Current and future of global myelodysplastic syndromes market outlook in the developed and emerging markets

The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

Regions/Countries that are expected to witness the fastest growth rates during the forecast period

The latest developments, market shares, and strategies that are employed by the major market players

View Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-myelodysplastic-syndromes-market

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Myelodysplastic Syndromes Market Business Growth Analysis, Trend, Outlook, Share, and Top Companies are Boston Biomedical, AbbVie Inc., Acceleron Pharma, Inc., BerGenBio ASA here

News-ID: 2082282 • Views: 844

More Releases from Data Bridge Market Research

Artificial Intelligence Market  2021 is Booming Worldwide with Key Players like …
Artificial Intelligence market report is presented to the clients that extend their reach to success. Market parameters covered in this advertising report can be listed as market definition, currency and pricing, market segmentation, market overview, premium insights, key insights and company profile of the key market players. Each parameter included in this business research report is again explored deeply for the better and actionable market insights. Geographical scope of the
Traction Battery Market 2021 is Booming Worldwide with Key Players GS Yuasa Inte …
Traction Battery market report also recognizes and analyses the growing trends along with major drivers, restraints, challenges and opportunities in the  industry. This finest market research document has been structured with the expertise and innovation of a team of researchers, forecasters, analysts and managers. The report acts as a supreme base for the competitor analysis, analyzing their core competencies, and drawing a competitive landscape for the  industry. Traction Battery market
Tablet Kiosk Market To See Astonishing Growth | Leading Players Are Calista, Ar …
Tablet Kiosk is a professional and a meticulous report which focuses on primary and secondary drivers, market share, leading segments and geographical analysis. It endows with an analytical measurement of the main challenges faced by the business currently and in the upcoming years. This market research report offers an insightful market data and information about  industry to businesses for making better decisions and defining business strategies. The Tablet Kiosk report
 Building Analytics Market To See Astonishing Growth | Leading Players Are ENG …
 Building Analytics Market Research Report 2021 is latest research study released by Data Bridge Market Research evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support.  Building Analytics market research report reviews diverse markets at a global level in accord with the client’s requirements and scoop out the best possible solutions and detailed information about the market trends. This particular market report is a source of

All 5 Releases


More Releases for Myelodysplastic

Myelodysplastic Syndrome Market Global Research and Clinical Analysis 2020
Global Myelodysplastic Syndrome Market research report published by market insight reports explores the current outlook in global and key regions from the perspective of Major Players, Countries, Product types and end industries. This report analyzes top players in the global market, and divides the Market into several parameters. This Myelodysplastic Syndrome Market research report identifies the competitive landscape of industries to understand the competition at International level. This report study describes
Myelodysplastic Syndrome Treatment Market Trends and Prospects by 2025
Myelodysplastic Syndrome Treatment Market: Overview Myelodysplastic syndrome (MDS) is a blood disorder caused due to the production of abnormal blood cells in bone marrow. Bone marrow failure leads to drop in the number of healthy blood cells in the body. In MDS, bone marrow does not produce healthy red blood cells, white blood cells, and/or platelets. Symptoms of MDS in the beginning are no specific than causes of pancytopenia i.e., deficiency
Myelodysplastic Syndrome Treatment to worth US$ 5.7 Billion by 2025
The Global Myelodysplastic Syndrome Treatment Market was valued at US$ 2,213.2 million in 2017 and is projected to expand at a CAGR of 12.7% during the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. Growing incidence of the bone marrow disorders and cytogenetic abnormalities expected to be the major factor driving growth of the global myelodysplastic syndrome treatment market over the foreseeable future. Myelodysplastic syndrome
Myelodysplastic Syndrome Market: Product Innovation to Underscore Lucrative Grow …
Growing prevalence of cancer fuels demand for treatments such as radiation and chemotherapy. Treatment of the cancer has led to increasing prevalence myelodysplastic syndrome globally. The myelodysplastic syndrome is mainly linked to various risk factors such as radiation and chemicals. Market Research Hub research report offers insights on the “Myelodysplastic Syndrome - Epidemiology Forecast to 2025”. This report offers a detailed insight that offer details and important opinions in the Myelodysplastic
Myelodysplastic Syndrome-Market Insights, Epidemiology and Market Forecast-2025
"The Report Myelodysplastic Syndrome-Market Insights, Epidemiology and Market Forecast-2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" ​DelveInsights Myelodysplastic Syndrome-Market Insights, Epidemiology and Market Forecast-Market Insights, Epidemiology and Market Forecast-2025 report provides an overview of the disease and in depth research related to Myelodysplastic Syndrome-Market Insights, Epidemiology and Market Forecast for the 7MM (United States, Germany, France, Italy, Spain and UK) for
Myelodysplastic Syndrome-Market Insights, Epidemiology and Market Forecast-2025
"The Report Myelodysplastic Syndrome-Market Insights, Epidemiology and Market Forecast-2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" ​DelveInsights Myelodysplastic Syndrome-Market Insights, Epidemiology and Market Forecast-Market Insights, Epidemiology and Market Forecast-2025 report provides an overview of the disease and in depth research related to Myelodysplastic Syndrome-Market Insights, Epidemiology and Market Forecast for the 7MM (United States, Germany, France, Italy, Spain and UK) for